Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-927,083
Closed -$6.14M 3275
2025
Q1
$6.14M Buy
927,083
+874,058
+1,648% +$4.84M 0.01% 972
2024
Q4
$273K Sell
53,025
-56,675
-52% -$311K ﹤0.01% 2259
2024
Q3
$675K Sell
109,700
-338,966
-76% -$2.42M ﹤0.01% 1821
2024
Q2
$3.53M Sell
448,666
-993,826
-69% -$8.37M ﹤0.01% 1137
2024
Q1
$11.8M Buy
+1,442,492
New +$10.1M 0.02% 693
2023
Q2
Sell
-238,387
Closed -$1.68M 3045
2023
Q1
$1.68M Sell
238,387
-522,480
-69% -$3.62M ﹤0.01% 1547
2022
Q4
$5.44M Sell
760,867
-799,366
-51% -$5.93M 0.01% 1140
2022
Q3
$9.61M Sell
1,560,233
-578,993
-27% -$4.13M 0.02% 917
2022
Q2
$15.2M Buy
2,139,226
+1,836,998
+608% +$14.4M 0.03% 612
2022
Q1
$2.19M Sell
302,228
-34,461
-10% -$233K ﹤0.01% 1995
2021
Q4
$1.8M Buy
336,689
+97,784
+41% +$476K ﹤0.01% 2106
2021
Q3
$1.1M Buy
+238,905
New +$883K ﹤0.01% 1954
2021
Q2
Sell
-150,087
Closed -$626K 3174
2021
Q1
$626K Buy
+150,087
New +$530K ﹤0.01% 1854
2019
Q4
Sell
-702,301
Closed -$3M 2134
2019
Q3
$3M Buy
+702,301
New +$2.43M 0.02% 647
2019
Q1
Sell
-92
Closed 2097
2018
Q4
$0 Buy
+92
New +$392 ﹤0.01% 1846
2016
Q3
Sell
-11,566
Closed -$183K 1162
2016
Q2
$183K Buy
+11,566
New +$185K ﹤0.01% 948

Other funds holding VRN

Marshall Wace's VRN Position: Q2 2025 in Review

Marshall Wace sold out of Veren (VRN) in Q2 2025, closing a stake of 927,083 shares — an estimated $6.14M sold.

Marshall Wace first reported a position in VRN in Q2 2016 and held it in 16 quarters. The position peaked at $15.2M in Q2 2022. 2 funds tracked by Wall St. Rank hold VRN as of Q2 2025.

  • Marshall Wace reported no remaining Veren position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 927,083 Veren shares in Q2 2025, an estimated $6.14M.
  • Marshall Wace first reported a position in Veren in Q2 2016 and held it in 16 quarters.
  • Marshall Wace's Veren position peaked at $15.2M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Veren as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.